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Abstract
Background—Reduced, left-lateralized P3 amplitude has been reported in several studies focusing
on electrophysiologic function in schizophrenia. Also, several lines of evidence suggest a similarity
between schizophrenia and schizotypal personality disorder (SPD). This study was undertaken to
determine the replicability of our previous finding of a left-lateralized P3 amplitude deficit in SPD.
Methods—We recorded event-related potentials in 21 SPD and 18 normal control subjects in an
auditory “oddball” P3 paradigm.
Results—In the SPD subjects, but not in the control subjects, there was lower P3 amplitude at T3
compared with T4.
Conclusions—These results are similar to the ones in our previous work and further support the
presence of a left-lateralized P3 deficit in SPD.
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Introduction
Schizotypal personality disorder (SPD) and schizophrenia may have a common genetic
diathesis (Baron et al 1985; Kendler et al 1993), possibly leading to a neurocognitive outcome
characterized by a similar, but less severe, dysfunction in SPD.
One of the more direct measures of neurocognitive function is event-related potentials (ERPs)
and, in particular, the auditory P3, a positive-going potential appearing within 250 to 600 msec
after the target stimulus. It has been related functionally to memory updating (Donchin
1981), and its latency and amplitude have been related to stimulus evaluation (Kutas et al
1977). In particular, the P300 left temporal amplitude reduction appears to be selective to
schizophrenia relative to affective psychosis in both first episode and chronic subjects (Ford
et al 1982; Salisbury et al 1998) and has been found in most (Faux et al 1988; Heidrich and
Strik, 1997; Salisbury et al 1992, 1994; Strik et al 1994; Turetsky et al 1998; Weisbrod et al
1997) but not all (e.g., Pfefferbaum et al 1989; Stefansson et al 1996) studies of schizophrenia.
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Data suggest that smaller P3 amplitude is associated with volume reductions in the left posterior
superior temporal gyrus (Seig et al 1991).
Given the genetic similarities between the two disorders, a P3 dysfunction, similar but less
severe to that found in schizophrenia, might be expected in SPD. In fact, somewhat reduced
(but not statistically significant) P3 amplitude was found in SPD when compared with normal
control subjects (Kalus et al 1991; Squires-Wheeler et al 1997; Trestman et al 1995) and to
borderline personality individuals (Kutcher et al 1987, 1989). Our previous study (Salisbury
et al 1996), reported a left-lateralized P3 amplitude abnormality in a sample of 11 unmedicated
SPD subjects and no differences at midline electrodes in 11 male subjects relative to 11 matched
normal control subjects. In our present study, we used an identical ERP protocol in a new group
of 19 unmedicated male SPD subjects, and 18 matched normal control subjects to evaluate the
replicability of our previous findings in a new group of subjects. We predicted a smaller P3
amplitude in the SPD group relative to comparison subjects, especially over the left temporal
area.
Methods and Materials
Subjects
Participating in the study were 21 right-handed individuals diagnosed with SPD using the SCID
and DSM-III-R (diagnostic reliability between two raters (MV and LS, κ = .87), meeting full
(≥5) diagnostic criteria, and 18 male comparison subjects, screened with SCID, and matched
for age and IQ. The SPD subjects responded to a newspaper advertisement calling for male,
shy individuals with few friends who felt they had special powers. The 18 normal comparison
men were recruited from an advertisement for an electroencephalogram (EEG) experiment.
All subjects were paid and signed a written informed consent form before entering the study.
English was the first language for all subjects.
The exclusion criteria for SPD and control subjects were 1) history of electroconvulsive
treatment; 2) neurological illness; 3) history of traumatic brain injury with a loss of
consciousness greater than 5 min; 4) drugs or medications affecting cognitive function in the
past year and any history of use or substance addiction, as defined by DSM-IIIR; 5) use of
neuroleptics at any time; and, 6) hearing, vision, or upper body motor impairment. SPD subjects
were allowed to have first-degree relatives with a history of psychiatric disease (Axis I disorder
[s] were present in six of the SPD subject’s first-degree relatives), whereas for normal control
subjects, this clinical history was an exclusion criterion. The SPD subjects’ average age was
37.78 (23–53, SD = 10.41), the IQ was 111.96 (80–139, SD = 14.71), parental socioeconomic
status (SES) was 3.6 (1–5, SD = 1.2). The comparison subjects’ average age was 38.9 (22–51,
SD = 9.83.), IQ was 116.8 (109–135, SD = 14.3), and parental SES was 3.53 (2–5, SD = 1.1).
There were no statistically significant group differences on any of the demographic measures,
with the exception of subject SES (SPD, 3.1; comparison subjects, 4.1; p < .01), which is not
a matching variable because it may reflect the effects of the disorder.
The P300 Protocol
The P300 protocol was identical to that used by Bruder and associates (1992). A Neuroscan
Stimulation program (Neuroscan, El Paso) generated 200 pure tones of 1.5 kHz (15% of all
tones) and 1 kHz (85% of all tones), 40 msec duration, 10 msec rise/fall, 97 dB (the dB levels
calibrated with dB meter), 1.2-sec interstimulus interval, were randomly presented to a subject
via Etymotic insert earphones (Neuroscan). The subject was asked to silently count the number
of high tones. Both groups were equally accurate in counting the number of target tones (95%
accuracy).
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An EEG was recorded during a cognitive task for 924 msec, with 100 msec prestimulus
baseline, sampled at the rate 256 with A/D rate of 250. Linked mastoids were used as reference;
caution was taken to keep both ears’ impedance at below 5 kΩ and at no more than .5 kΩ
difference. The ERP to target (high tones) and nontarget (low tones) was averaged offline.
Before averaging, the EEG was corrected for eye movements using Semlitsch (Semlitsch et al
1986) algorithm. Epochs containing voltage exceeding ±75 mV at any electrode location were
rejected from further analysis. The averages were then filtered with a low-pass filter of 8 Hz,
24 dB/octave rolloff to remove noise and alpha contamination from the data.
The P300 peak latency was measured within 320 to 420 msec poststimulus latency window,
and the amplitude was calculated as the mean integrated voltage under the curve within the
same latency window. The amplitude and latency data were measured from three midline (Fz,
Cz, Pz) and four temporal electrodes (T3/4 and T5/6) known to be sensitive to lateralized
voltage abnormalities previously reported in schizophrenic and schizotypal subjects (McCarley
et al 1993, Salisbury et al 1996). For P3 amplitude values at lateral electrodes, the P300
amplitude data were normalized using Cz voltage following McCarthy and Woods (1985)
recommendations to remove the problems of variance misallocation before statistical analyses.
Results
The amplitude and latency data were submitted to repeated measures analyses of variance
(ANOVAs) for two electrode chains (midline: Fz, Cz, Pz; and lateral: T3, T4, T5, T6), with
group (two levels: SPD and control subjects) as a between variable and electrode as a within
variable for midline (three levels: Fz, Cz, Pz); for the lateral electrodes two within factors were
analyzed, hemisphere (two levels: left and right) and electrode (two levels). The ANOVA for
the midline electrode chain revealed the main effect of group [F(1,35) = 9.018, p < .005] with
P3 amplitude in the SPD group smaller than in the normal control group (Figure 1). In the
ANOVA for P3 amplitude at lateral electrode chain, no significant group × side interaction
was found; however, given our prediction of abnormal amplitude distribution at lateral sites
and the presence of unequal variances in the control and SPD groups (which may cause loss
of power in ANOVA comparisons), we used unidirectional one-sample t tests to examine
amplitude distribution within each group for T3/4 and T5/6; the tests yielded a significant
difference within the SPD group for T3/T5 [t(20) = −1.804, p < .043] and a trend-level
difference at T5/T6 [t(18) = −1.676, p < .055; Figure 2]. Lower amplitude was found at T3 (.
37, SD = .6) relative to T4 (.57, SD = .6), and at T5 (.50, SD = .4) and T6 (.64, SD = .45) in
the SPD group. No difference in amplitude distribution at analogous electrode sites was found
within the control group (T3 .42, SD = .2 vs. T4 .46, SD = .27; T5 .44, SD = .2 vs. T6 .49, SD
= .14). No group differences were found in the P3 latency, measured at midline and lateral
electrodes, although there was a trend toward a prolonged P3 latency (p > .1) at midline in the
SPD individuals.
Discussion
The aim of this study was to extend the findings of reduced, left-lateralized P3 amplitude in
the SPD reported previously (Salisbury et al 1996) to a new group of subjects and thus better
assess the generalizability of this finding to SPD population. Reduced P3 amplitude was found
at midline electrodes (Figure 1), the finding different than that reported in previous studies
where reduced P3 amplitude in SPD did not distinguish between normal and SPD subjects on
statistical tests. It may be that this group difference is due to a slow positive wave that developed
around P3 latency range and persisted for the rest of the epoch. At lateral electrodes, the results
indicate that there was a small but significant reduction of P3 amplitude on the left side relative
to the right side within the SPD group. Such reduction was not found in the normal control
group. Importantly, the reduction was small enough not to be evinced in the group by
Niznikiewicz et al. Page 3
Biol Psychiatry. Author manuscript; available in PMC 2010 March 26.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
hemisphere interaction at lateral temporal sides. The group differences consisted in the
asymmetrical voltage distribution at T3 and its right-side homologue, T4, within the SPD group
(Figure 2) and at a trend level at T5 and T6. In contrast, among normal control subjects, there
was no statistical difference in the P3 amplitude distribution as a function of the left and right
hemisphere. This finding is consistent with earlier reports of P3 abnormality in schizophrenic
patients where it was suggested that an abnormality in structures of the left superior temporal
gyrus selectively influences the generators contributing to the surface voltage at lateral sites,
resulting in the left-side amplitude reduction. Because no such abnormality is expected in the
normal subjects, no difference in lateral voltage distribution is expected. The results of this
study suggest that a similar mechanism may be at work in the SPD sample. As has been noted,
however, the impairment seems to be much more subtle; in this study, the laterality reversal
was demonstrated only in within-group comparisons and not in direct hemisphere-by-site
comparisons, as was the case with schizophrenic subjects. This is arguably a less strong result
than a direct demonstration of a group-by-site interaction.
The differences in variance may be responsible. One of the factors influencing variability
maybe the heterogeneity of SPD groups, where different degrees of impairment are found
across samples. Also, the current results suggest that in terms of the electrophysiologic
response, P3, the group separation between SPD and normal control subjects is smaller than
between normal control and schizophrenic subjects, in agreement with their milder clinical
presentation.
The study extends the findings reported in Salisbury et al (1996) in that a left-lateralized
amplitude deficit and a latency prolongation were found in this new SPD sample. The results
are different in that statistically significant separation in P3 voltage was found at midline
electrodes and also by the fact that the statistical difference reported in Salisbury et al (1996)
was at T5/6, and it was demonstrated in between-group rather than within-group comparisons.
These differences underline the issue of the heterogeneity of the SPD population that may
escape traditional sample comparisons, such as age, parental SES or education, all of which
did not differ between the two groups.
The fact that paradigms used to probe P3 response in schizophrenia produce similar but less
pronounced group differences between SPD and normal comparison subjects suggests that
using the same paradigm to assess brain function across different clinical populations may be
useful, as well as the fact that there may be a similarity of dysfunction in schizophrenia and
SPD as measured by P3 oddball paradigm. Clinically, our results provide an additional piece
of evidence for the common, probably genetically mediated, neurophysiologic link between
schizophrenia, an Axis I disorder, and SPD, which is classified as an Axis II personality
disorder.
In summary, the results of this study lend further support to the notion that SPD bears
electrophysiologic features similar to those found in schizophrenia, although the lateral
asymmetry group effect was attenuated in SPD. Further studies are needed to identify possible
protective factors preventing individuals from developing schizophrenic symptoms. Also,
further studies should focus on heterogeneity of the SPD group. We believe that both of these
lines of inquiry might provide a better understanding of the clinical and neurophysiologic
differences between SPD and schizophrenia.
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Figure 1.
Grand average waveforms of 18 normal control (NC; thicker line) subjects and 21 schizotypal
personality disorder (SPD; thinner line) individuals to rare tones in the P300 auditory oddball
paradigm at midline.
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Figure 2.
Grand average waveforms of 18 normal control (NC) subjects and 21 schizotypal personality
disorder (SPD) individuals to rare tones in the P300 auditory oddball paradigm at lateral
electrodes T3 and T4.
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